The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Prevalence and causes of vision loss in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019
Open accessAbstract
BACKGROUND: Vision loss is an important public health issue in China, but a detailed understanding of national and regional trends in its prevalence and causes, which could inform health policy, has not been available. This study aimed to assess the prevalence, causes, and regional distribution of vision impairment and blindness in China in 1990 and 2019. METHODS: Data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 were used to estimate the prevalence of moderate and severe vision impairment and blindness in China and compare with other Group of 20 (G20) countries. We used GBD methodology to systematically analyse all available demographic and epidemiological data at the provincial level in China. We compared the age-standardised prevalences across provinces, and the changes in proportion of vision loss attributable to various eye diseases in 1990 and 2019. We used two different counterfactual scenarios with respect to population structure and age-specific prevalence to assess the contribution of population growth and ageing to trends in vision loss. FINDINGS: In 2019, the age-standardised prevalence was 2·57% (uncertainty interval [UI] 2·28-2·86) for moderate vision impairment, 0·25% (0·22-0·29) for severe vision impairment, and 0·48% (0·43-0·54) for blindness in China, which were all below the global average, but the prevalence of moderate and severe vision impairment had increased more rapidly than in other G20 countries from 1990 to 2019. The prevalence of vision loss increased with age, and the main causes of vision loss varied across age groups. The leading causes of vision impairment in China were uncorrected refractive error, cataract, and macular degeneration in both 1990 and 2019 in the overall population. From 1990 to 2019, the number of people with moderate vision impairment increased by 133·67% (from 19·65 to 45·92 million), those with severe vision impairment increased by 147·14% (from 1·89 to 4·67 million), and those with blindness increased by 64·35% (from 5·29 to 8·69 million); in each case, 20·16% of the increase could be explained by population growth. The contributions to these changes by population ageing were 87·22% for moderate vision impairment, 116·06% for severe vision impairment, and 99·22% for blindness, and the contributions by age-specific prevalence were 26·29% for moderate vision impairment, 10·91% for severe vision impairment, and -55·04% for blindness. The prevalence and specific causes of vision loss differed across provinces. INTERPRETATION: Although a comprehensive national policy to prevent blindness is in place, public awareness of visual health needs improving, and reducing the prevalence of moderate and severe vision impairment should be prioritised in future work. FUNDING: China National Key Research and Development Programme and Beijing Municipal Special Funds for Medical Research on Public Welfare Development and Reform.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Self-citationWang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596
Self-citation
Cited by
Ma, Q., Li, R., Wang, L., Yin, P., Wang, Y., Yan, C., Ren, Y., Qian, Z., Vaughn, M. G., McMillin, S. E., et al. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00228-0 · Cited by 885
Self-citationGlobal burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019
Jin, X., Ren, J., Li, R., Gao, Y., Zhang, H., Li, J., Zhang, J., Wang, X., & Wang, G. (2021) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.100986 · Cited by 323
Self-citationPiao, J., Huang, Y., Han, C., Li, Y., Xu, Y., Liu, Y., & He, X. (2022) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-022-02040-4 · Cited by 264
Liu, H., Li, R., Zhang, Y., Zhang, K., Yusufu, M., Liu, Y., Mou, D., Chen, X., Tian, J., Li, H., et al. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(22)00554-x · Cited by 111
Self-citationChen, S., Sun, H., Song, Y., Zhang, M., Huang, W., Zhao, C., Wang, Y., Wang, J., Meng, H., Zhou, L., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.06.067 · Cited by 49
Self-citation
Metadata
- Authors
- Xu, T., Wang, B., Liu, H., Wang, H., Yin, P., Dong, W., Li, J., Wang, Y. X., Yusufu, M., Briant, P., Reinig, N., Ashbaugh, C., Adelson, J., Vos, T., Bourne, R., Wang, N., & Zhou, M.
- Venue
- The Lancet Public Health
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 5
- Issue
- 12
- Pages
- e682-e691
- ISSN
- 2468-2667 (ISSN-L)
- OpenAlex
- W3108456188
- Cited by
- 235
- References
- 2
- FWCI
- 15.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and causes of vision loss in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019. https://app.cochat.ai/papers/10.1016/s2468-2667(20)30254-1
- The paper
- Xu, T., Wang, B., Liu, H., Wang, H., Yin, P., Dong, W., Li, J., Wang, Y. X., Yusufu, M., Briant, P., Reinig, N., Ashbaugh, C., Adelson, J., Vos, T., Bourne, R., Wang, N., & Zhou, M. (2020). Prevalence and causes of vision loss in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019. The Lancet Public Health. https://doi.org/10.1016/s2468-2667(20)30254-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.